A Mark Wan

Affiliations

  • at Talphera Inc. (TLPH), 2024-06-24
  • Executive Chairman at Athlon Acquisition Corp. (SWETU), 2021-01-12
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-11-20
  • Other at Nevro Corp (NVRO), 2014-11-12
  • Director at Epocrates Inc (EPOC), 2013-03-14
  • Large Shareholder at Liposcience Inc (LPDX), 2013-02-01
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACRX $3.31 52,213 $172,825.03 139,621 2012-12-07 Filing
ACRX $3.31 2,364,705 $7,827,173.55 6,323,534 2012-12-07 Filing
ACRX $3.40 4,613 $15,684.20 87,408 2012-05-29 Filing
ACRX $3.40 208,911 $710,297.40 3,958,829 2012-05-29 Filing
ACRX $3.40 3,631 $12,345.40 199,174 2012-05-29 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACRX $12.36 11,250 $139,050.00 126,153 2014-03-10 Filing
ACRX $11.96 459 $5,489.64 137,403 2014-03-07 Filing
ACRX $12.39 1,759 $21,790.84 137,862 2014-03-07 Filing
ACRX $12.36 509,520 $6,297,667.20 5,713,569 2014-03-10 Filing
ACRX $11.96 20,800 $248,768.00 6,223,089 2014-03-07 Filing